Benitec Biopharma Inc.
BNTC
$14.61
-$0.33-2.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 103.58M | 78.28M | 67.84M | 50.87M | 14.14M |
| Total Receivables | 3.00K | 2.00K | 4.00K | 229.00K | 53.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 361.00K | 366.00K | 426.00K | 516.00K | 157.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 63.00K | 62.00K | 64.00K | 63.00K | 13.00K |
| Total Current Assets | 104.01M | 78.71M | 68.34M | 51.67M | 14.37M |
|
|
|||||
| Total Current Assets | 104.01M | 78.71M | 68.34M | 51.67M | 14.37M |
| Net Property, Plant & Equipment | 1.11M | 288.00K | 358.00K | 449.00K | 539.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 90.00K | 67.00K | 81.00K | 87.00K | 94.00K |
| Total Assets | 105.21M | 79.07M | 68.77M | 52.21M | 15.00M |
|
|
|||||
| Total Accounts Payable | 433.00K | 593.00K | 903.00K | 1.35M | 815.00K |
| Total Accrued Expenses | 856.00K | 671.00K | 734.00K | 647.00K | 666.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 346.00K | 137.00K | 211.00K | 284.00K | 292.00K |
| Total Finance Division Other Current Liabilities | 5.39M | 1.69M | 2.71M | 2.64M | 1.66M |
| Total Other Current Liabilities | 5.39M | 1.69M | 2.71M | 2.64M | 1.66M |
| Total Current Liabilities | 7.03M | 3.09M | 4.55M | 4.92M | 3.44M |
|
|
|||||
| Total Current Liabilities | 7.03M | 3.09M | 4.55M | 4.92M | 3.44M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 613.00K | -- | -- | -- | 62.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 38.00K | 41.00K | 38.00K | -- |
| Total Liabilities | 7.64M | 3.13M | 4.59M | 4.96M | 3.50M |
|
|
|||||
| Common Stock & APIC | 310.32M | 279.30M | 260.49M | 238.40M | 197.26M |
| Retained Earnings | -212.03M | -202.68M | -195.32M | -190.26M | -184.92M |
| Treasury Stock & Other | -716.00K | -688.00K | -993.00K | -892.00K | -835.00K |
| Total Common Equity | 97.57M | 75.94M | 64.18M | 47.25M | 11.50M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 97.57M | 75.94M | 64.18M | 47.25M | 11.50M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 97.57M | 75.94M | 64.18M | 47.25M | 11.50M |
|
|
|||||